# 4D Molecular Therapeutics, Inc. (FDMT)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/FDMT/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 3.05M | $ -68.76M | $ -68.13M | $ 20.54M | $ 451.84M |
| 2025 | $ 87.25M | $ -143.46M | $ -112.96M | $ 21.41M | $ 505.66M |
| 2024 | $ 38.9K | $ -169.09M | $ -145.44M | $ 24.61M | $ 510.61M |
| 2023 | $ 22.41M | $ -109.03M | $ -84.95M | $ 14.67M | $ 307.83M |
| 2022 | $ 3.49M | $ -120.08M | $ -109.72M | $ 16.12M | $ 231.34M |
| 2021 | $ 21.44M | $ -84.77M | $ -93.00M | $ 16.45M | $ 319.11M |
| 2020 | $ 17.34M | $ -72.22M | $ -66.13M | $ 0 | $ 256.39M |
| 2019 | $ 9.02M | $ -63.64M | $ -51.52M | $ 0 | $ -72.97M |
| 2018 | $ 18.66M | $ -12.61M | $ -22.01M | $ 0 | $ -27.59M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.05 |
| Liabilities / Eq | 0.14 |
| Current Ratio | 9.34 |

## Other views

- [Metrics](https://sponda.capital/en/FDMT.md)
- [Charts](https://sponda.capital/en/FDMT/charts.md)
- [Compare](https://sponda.capital/en/FDMT/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.